Liposomal Doxorubicin Market Report by Product (Doxil/Caelyx, Lipodox, Myocet, and Others), Application (Leukemia, Bone Sarcoma, Breast Cancer, Endometrial Cancer, Kidney Cancer, Multiple Myeloma, Kaposi Sarcoma, and Others), and Region 2025-2033

Liposomal Doxorubicin Market Report by Product (Doxil/Caelyx, Lipodox, Myocet, and Others), Application (Leukemia, Bone Sarcoma, Breast Cancer, Endometrial Cancer, Kidney Cancer, Multiple Myeloma, Kaposi Sarcoma, and Others), and Region 2025-2033

Report Format: PDF+Excel | Report ID: SR112025A3921

1   Preface
2   Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Introduction

    4.1    Overview
    4.2    Key Industry Trends
5   Global Liposomal Doxorubicin Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6   Market Breakup by Product
    6.1    Doxil/Caelyx
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Lipodox
        6.2.1 Market Trends
        6.2.2 Market Forecast
    6.3    Myocet
        6.3.1 Market Trends
        6.3.2 Market Forecast
    6.4    Others
        6.4.1 Market Trends
        6.4.2 Market Forecast
7   Market Breakup by Application
    7.1    Leukemia
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Bone Sarcoma
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Breast Cancer
        7.3.1 Market Trends
        7.3.2 Market Forecast
    7.4    Endometrial Cancer
        7.4.1 Market Trends
        7.4.2 Market Forecast
    7.5    Kidney Cancer
        7.5.1 Market Trends
        7.5.2 Market Forecast
    7.6    Multiple Myeloma
        7.6.1 Market Trends
        7.6.2 Market Forecast
    7.7    Kaposi Sarcoma
        7.7.1 Market Trends
        7.7.2 Market Forecast
    7.8    Others
        7.8.1 Market Trends
        7.8.2 Market Forecast
8   Market Breakup by Region
    8.1    North America
        8.1.1 United States
           8.1.1.1 Market Trends
           8.1.1.2 Market Forecast
        8.1.2 Canada
           8.1.2.1 Market Trends
           8.1.2.2 Market Forecast
    8.2    Asia-Pacific
        8.2.1 China
           8.2.1.1 Market Trends
           8.2.1.2 Market Forecast
        8.2.2 Japan
           8.2.2.1 Market Trends
           8.2.2.2 Market Forecast
        8.2.3 India
           8.2.3.1 Market Trends
           8.2.3.2 Market Forecast
        8.2.4 South Korea
           8.2.4.1 Market Trends
           8.2.4.2 Market Forecast
        8.2.5 Australia
           8.2.5.1 Market Trends
           8.2.5.2 Market Forecast
        8.2.6 Indonesia
           8.2.6.1 Market Trends
           8.2.6.2 Market Forecast
        8.2.7 Others
           8.2.7.1 Market Trends
           8.2.7.2 Market Forecast
    8.3    Europe
        8.3.1 Germany
           8.3.1.1 Market Trends
           8.3.1.2 Market Forecast
        8.3.2 France
           8.3.2.1 Market Trends
           8.3.2.2 Market Forecast
        8.3.3 United Kingdom
           8.3.3.1 Market Trends
           8.3.3.2 Market Forecast
        8.3.4 Italy
           8.3.4.1 Market Trends
           8.3.4.2 Market Forecast
        8.3.5 Spain
           8.3.5.1 Market Trends
           8.3.5.2 Market Forecast
        8.3.6 Russia
           8.3.6.1 Market Trends
           8.3.6.2 Market Forecast
        8.3.7 Others
           8.3.7.1 Market Trends
           8.3.7.2 Market Forecast
    8.4    Latin America
        8.4.1 Brazil
           8.4.1.1 Market Trends
           8.4.1.2 Market Forecast
        8.4.2 Mexico
           8.4.2.1 Market Trends
           8.4.2.2 Market Forecast
        8.4.3 Others
           8.4.3.1 Market Trends
           8.4.3.2 Market Forecast
    8.5    Middle East and Africa
        8.5.1 Market Trends
        8.5.2 Market Breakup by Country
        8.5.3 Market Forecast
9   SWOT Analysis
    9.1    Overview
    9.2    Strengths
    9.3    Weaknesses
    9.4    Opportunities
    9.5    Threats
10  Value Chain Analysis
11  Porters Five Forces Analysis

    11.1    Overview
    11.2    Bargaining Power of Buyers
    11.3    Bargaining Power of Suppliers
    11.4    Degree of Competition
    11.5    Threat of New Entrants
    11.6    Threat of Substitutes
12  Price Analysis
13  Competitive Landscape

    13.1    Market Structure
    13.2    Key Players
    13.3    Profiles of Key Players
        13.3.1    Baxter International Inc.
           13.3.1.1 Company Overview
           13.3.1.2 Product Portfolio
           13.3.1.3 Financials
           13.3.1.4 SWOT Analysis
        13.3.2    Cipla Inc.
           13.3.2.1 Company Overview
           13.3.2.2 Product Portfolio
           13.3.2.3 Financials
           13.3.2.4 SWOT Analysis
        13.3.3    Johnson & Johnson
           13.3.3.1 Company Overview
           13.3.3.2 Product Portfolio
           13.3.3.3 Financials
           13.3.3.4 SWOT Analysis
        13.3.4    Merck KGaA
           13.3.4.1 Company Overview
           13.3.4.2 Product Portfolio
           13.3.4.3 Financials
           13.3.4.4 SWOT Analysis
        13.3.5    Pfizer Inc.
           13.3.5.1 Company Overview
           13.3.5.2 Product Portfolio
           13.3.5.3 Financials
           13.3.5.4 SWOT Analysis
        13.3.6    Sun Pharmaceutical Industries Ltd
           13.3.6.1 Company Overview
           13.3.6.2 Product Portfolio
           13.3.6.3 Financials
           13.3.6.4 SWOT Analysis
        13.3.7    Teva Pharmaceutical Industries Ltd
           13.3.7.1 Company Overview
           13.3.7.2 Product Portfolio
           13.3.7.3 Financials
           13.3.7.4 SWOT Analysis
        13.3.8    TTY Biopharm Company Limited
           13.3.8.1 Company Overview
           13.3.8.2 Product Portfolio
           13.3.8.3 Financials
        13.3.9    Zydus Cadila
           13.3.9.1 Company Overview
           13.3.9.2 Product Portfolio

List of Figures

Figure 1: Global: Liposomal Doxorubicin Market: Major Drivers and Challenges
Figure 2: Global: Liposomal Doxorubicin Market: Sales Value (in Billion USD), 2019-2024
Figure 3: Global: Liposomal Doxorubicin Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 4: Global: Liposomal Doxorubicin Market: Breakup by Product (in %), 2024
Figure 5: Global: Liposomal Doxorubicin Market: Breakup by Application (in %), 2024
Figure 6: Global: Liposomal Doxorubicin Market: Breakup by Region (in %), 2024
Figure 7: Global: Liposomal Doxorubicin (Doxil/Caelyx) Market: Sales Value (in Million USD), 2019 & 2024
Figure 8: Global: Liposomal Doxorubicin (Doxil/Caelyx) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 9: Global: Liposomal Doxorubicin (Lipodox) Market: Sales Value (in Million USD), 2019 & 2024
Figure 10: Global: Liposomal Doxorubicin (Lipodox) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 11: Global: Liposomal Doxorubicin (Myocet) Market: Sales Value (in Million USD), 2019 & 2024
Figure 12: Global: Liposomal Doxorubicin (Myocet) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 13: Global: Liposomal Doxorubicin (Other Products) Market: Sales Value (in Million USD), 2019 & 2024
Figure 14: Global: Liposomal Doxorubicin (Other Products) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 15: Global: Liposomal Doxorubicin (Leukemia) Market: Sales Value (in Million USD), 2019 & 2024
Figure 16: Global: Liposomal Doxorubicin (Leukemia) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 17: Global: Liposomal Doxorubicin (Bone Sarcoma) Market: Sales Value (in Million USD), 2019 & 2024
Figure 18: Global: Liposomal Doxorubicin (Bone Sarcoma) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 19: Global: Liposomal Doxorubicin (Breast Cancer) Market: Sales Value (in Million USD), 2019 & 2024
Figure 20: Global: Liposomal Doxorubicin (Breast Cancer) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 21: Global: Liposomal Doxorubicin (Endometrial Cancer) Market: Sales Value (in Million USD), 2019 & 2024
Figure 22: Global: Liposomal Doxorubicin (Endometrial Cancer) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 23: Global: Liposomal Doxorubicin (Kidney Cancer) Market: Sales Value (in Million USD), 2019 & 2024
Figure 24: Global: Liposomal Doxorubicin (Kidney Cancer) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 25: Global: Liposomal Doxorubicin (Multiple Myeloma) Market: Sales Value (in Million USD), 2019 & 2024
Figure 26: Global: Liposomal Doxorubicin (Multiple Myeloma) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 27: Global: Liposomal Doxorubicin (Kaposi Sarcoma) Market: Sales Value (in Million USD), 2019 & 2024
Figure 28: Global: Liposomal Doxorubicin (Kaposi Sarcoma) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 29: Global: Liposomal Doxorubicin (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
Figure 30: Global: Liposomal Doxorubicin (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 31: North America: Liposomal Doxorubicin Market: Sales Value (in Million USD), 2019 & 2024
Figure 32: North America: Liposomal Doxorubicin Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 33: United States: Liposomal Doxorubicin Market: Sales Value (in Million USD), 2019 & 2024
Figure 34: United States: Liposomal Doxorubicin Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 35: Canada: Liposomal Doxorubicin Market: Sales Value (in Million USD), 2019 & 2024
Figure 36: Canada: Liposomal Doxorubicin Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 37: Asia-Pacific: Liposomal Doxorubicin Market: Sales Value (in Million USD), 2019 & 2024
Figure 38: Asia-Pacific: Liposomal Doxorubicin Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 39: China: Liposomal Doxorubicin Market: Sales Value (in Million USD), 2019 & 2024
Figure 40: China: Liposomal Doxorubicin Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 41: Japan: Liposomal Doxorubicin Market: Sales Value (in Million USD), 2019 & 2024
Figure 42: Japan: Liposomal Doxorubicin Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 43: India: Liposomal Doxorubicin Market: Sales Value (in Million USD), 2019 & 2024
Figure 44: India: Liposomal Doxorubicin Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 45: South Korea: Liposomal Doxorubicin Market: Sales Value (in Million USD), 2019 & 2024
Figure 46: South Korea: Liposomal Doxorubicin Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 47: Australia: Liposomal Doxorubicin Market: Sales Value (in Million USD), 2019 & 2024
Figure 48: Australia: Liposomal Doxorubicin Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 49: Indonesia: Liposomal Doxorubicin Market: Sales Value (in Million USD), 2019 & 2024
Figure 50: Indonesia: Liposomal Doxorubicin Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 51: Others: Liposomal Doxorubicin Market: Sales Value (in Million USD), 2019 & 2024
Figure 52: Others: Liposomal Doxorubicin Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 53: Europe: Liposomal Doxorubicin Market: Sales Value (in Million USD), 2019 & 2024
Figure 54: Europe: Liposomal Doxorubicin Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 55: Germany: Liposomal Doxorubicin Market: Sales Value (in Million USD), 2019 & 2024
Figure 56: Germany: Liposomal Doxorubicin Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 57: France: Liposomal Doxorubicin Market: Sales Value (in Million USD), 2019 & 2024
Figure 58: France: Liposomal Doxorubicin Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 59: United Kingdom: Liposomal Doxorubicin Market: Sales Value (in Million USD), 2019 & 2024
Figure 60: United Kingdom: Liposomal Doxorubicin Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 61: Italy: Liposomal Doxorubicin Market: Sales Value (in Million USD), 2019 & 2024
Figure 62: Italy: Liposomal Doxorubicin Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 63: Spain: Liposomal Doxorubicin Market: Sales Value (in Million USD), 2019 & 2024
Figure 64: Spain: Liposomal Doxorubicin Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 65: Russia: Liposomal Doxorubicin Market: Sales Value (in Million USD), 2019 & 2024
Figure 66: Russia: Liposomal Doxorubicin Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 67: Others: Liposomal Doxorubicin Market: Sales Value (in Million USD), 2019 & 2024
Figure 68: Others: Liposomal Doxorubicin Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 69: Latin America: Liposomal Doxorubicin Market: Sales Value (in Million USD), 2019 & 2024
Figure 70: Latin America: Liposomal Doxorubicin Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 71: Brazil: Liposomal Doxorubicin Market: Sales Value (in Million USD), 2019 & 2024
Figure 72: Brazil: Liposomal Doxorubicin Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 73: Mexico: Liposomal Doxorubicin Market: Sales Value (in Million USD), 2019 & 2024
Figure 74: Mexico: Liposomal Doxorubicin Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 75: Others: Liposomal Doxorubicin Market: Sales Value (in Million USD), 2019 & 2024
Figure 76: Others: Liposomal Doxorubicin Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 77: Middle East and Africa: Liposomal Doxorubicin Market: Sales Value (in Million USD), 2019 & 2024
Figure 78: Middle East and Africa: Liposomal Doxorubicin Market: Breakup by Country (in %), 2024
Figure 79: Middle East and Africa: Liposomal Doxorubicin Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 80: Global: Liposomal Doxorubicin Industry: SWOT Analysis
Figure 81: Global: Liposomal Doxorubicin Industry: Value Chain Analysis
Figure 82: Global: Liposomal Doxorubicin Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Liposomal Doxorubicin Market: Key Industry Highlights, 2024 and 2033
Table 2: Global: Liposomal Doxorubicin Market Forecast: Breakup by Product (in Million USD), 2025-2033
Table 3: Global: Liposomal Doxorubicin Market Forecast: Breakup by Application (in Million USD), 2025-2033
Table 4: Global: Liposomal Doxorubicin Market Forecast: Breakup by Region (in Million USD), 2025-2033
Table 5: Global: Liposomal Doxorubicin Market: Competitive Structure
Table 6: Global: Liposomal Doxorubicin Market: Key Players

Liposomal Doxorubicin Market Report by Product (Doxil/Caelyx, Lipodox, Myocet, and Others), Application (Leukemia, Bone Sarcoma, Breast Cancer, Endometrial Cancer, Kidney Cancer, Multiple Myeloma, Kaposi Sarcoma, and Others), and Region 2025-2033
Purchase Options New Year Sale
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials